Valuation
- Market cap
- 0
- Revenue TTM
- $1,370,000
- Net income TTM
- $-14,420,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -1,052.55%
- Debt to equity
- 0.00
Trading
- Volume
- 108
- Avg volume
- 6,028
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- 7.00
- Analysts
- —
- Price target
- $1.00
Company profile
Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 650 812 8700
- Address
- 630 Fifth Avenue, Suite 2260, New York, United States
Latest news
No headlines yet.
